desogestrel has been researched along with Venous Thrombosis in 33 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (18.18) | 18.2507 |
2000's | 22 (66.67) | 29.6817 |
2010's | 4 (12.12) | 24.3611 |
2020's | 1 (3.03) | 2.80 |
Authors | Studies |
---|---|
Abdalhabib, EK; Ahmed, OAB; Alfeel, AH; Algarni, A; Babker, AMA; Elfaki, EM; Elzein, HO; Habiballah, EM; Hamza, A; Kumar, P; Osman, HA; Saboor, M; Yousif, TYE | 1 |
de Bastos, M; Dekkers, OM; Helmerhorst, FM; Rosendaal, FR; Stegeman, BH; Stijnen, T; Van Hylckama Vlieg, A | 1 |
Matarasso, A; Myers, RS; Paresi, RJ | 1 |
Pannucci, CJ | 1 |
Cannegieter, SC; Helmerhorst, FM; Lijfering, WM; Roach, RE; Rosendaal, FR; van Hylckama Vlieg, A | 1 |
Fabris, F; Girolami, A; Girolami, B; Spiezia, L; Vianello, F | 1 |
Goldzieher, JW; Shulman, LP | 1 |
Iversen, OE | 1 |
Bouma, BN; Deguchi, H; Griffin, JH; Lee, YM; Middeldorp, S | 1 |
Green, P; Roberts, S | 1 |
Szarewski, A | 1 |
Azevedo, GD; Ferriani, RA; Garcia, AA; Gomes, MK; Pintão, MC; Silva-de-Sá, MF; Vieira, CS | 1 |
Gold, MA; Kaizar, EE; Kelleher, KJ; O'Brien, SH | 1 |
Helmerhorst, FM; Rosendaal, FR; Vandenbroucke, JP | 1 |
Weiss, G | 1 |
Mayor, S | 1 |
Farmer, RD; Lawrenson, R; Leydon, GM; Todd, J; Williams, TJ | 1 |
Bruppacher, R; Heinemann, LA; Kühl-Habichl, D; Lewis, MA; MacRae, KD; Spitzer, WO | 1 |
Cusson, J; Heinemann, L; Lewis, M; Rainville, B; Spitzer, WO; Suissa, S | 1 |
Skjeldestad, FE | 1 |
Kluft, C | 1 |
Bouma, BN; Büller, HR; Meijers, JC; Middeldorp, S; Prins, MH; Rosing, J; Tans, G; van den Ende, AE; van Enk, A | 1 |
Colau, JC | 1 |
Meurer, LN; Slawson, JG | 1 |
Curvers, J; Rosing, J; Tans, G | 1 |
Bounds, W; Furs , SA; Guillebaud, J; Johnson, J; Machin, SJ; Mackie, IJ; Piegsa, K | 1 |
Berlin, JA; Hennessy, S; Kinman, JL; Marcus, SM; Margolis, DJ; Strom, BL | 1 |
Olsen, J | 1 |
Milsom, I; Odlind, V; Ostlund, I; Persson, E; von Schoultz, B | 1 |
Milsom, I; Odlind, V; Persson, I; Victor, A | 1 |
Black, C; Jick, H; Kaye, JA | 1 |
7 review(s) available for desogestrel and Venous Thrombosis
Article | Year |
---|---|
Combined oral contraceptives: venous thrombosis.
Topics: Androstenes; Contraceptives, Oral, Combined; Cyproterone; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norpregnenes; Pulmonary Embolism; Randomized Controlled Trials as Topic; Venous Thrombosis | 2014 |
The truth about oral contraceptives and venous thromboembolism.
Topics: Androstenes; Bias; Confounding Factors, Epidemiologic; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Risk Factors; Thromboembolism; Time Factors; Venous Thrombosis; Women's Health | 2003 |
[Third-generation oral contraceptives--how big is the risk of venous thrombosis?].
Topics: Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Meta-Analysis as Topic; Norpregnenes; Risk Factors; Thromboembolism; Venous Thrombosis | 2004 |
Hormonal contraception: recent advances.
Topics: Contraception; Contraceptive Agents, Female; Desogestrel; Drug Combinations; Ethisterone; Female; Humans; Levonorgestrel; Male; Medroxyprogesterone Acetate; Norgestrel; Oximes; Venous Thrombosis; Women's Health | 2006 |
[Contraception].
Topics: Cardiovascular Diseases; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Contraindications; Desogestrel; Drug Interactions; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Myocardial Infarction; Progestins; Risk Factors; Stroke; Venous Thrombosis; Vinyl Compounds | 2000 |
Oral contraceptives, thrombosis and haemostasis.
Topics: Activated Protein C Resistance; Contraceptives, Oral; Desogestrel; Female; Hemostasis; Humans; Norpregnenes; Risk Factors; Venous Thrombosis | 2001 |
Risk of venous thromboembolism from oral contraceptives containing gestodene and desogestrel versus levonorgestrel: a meta-analysis and formal sensitivity analysis.
Topics: Contraceptives, Oral; Desogestrel; Female; Humans; Levonorgestrel; Norpregnenes; Odds Ratio; Risk Factors; Venous Thrombosis | 2001 |
3 trial(s) available for desogestrel and Venous Thrombosis
Article | Year |
---|---|
Decreased plasma sensitivity to activated protein C by oral contraceptives is associated with decreases in plasma glucosylceramide.
Topics: Activated Protein C Resistance; Chromatography, High Pressure Liquid; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Estradiol; Ethinyl Estradiol; Female; Glucosylceramides; Humans; Levonorgestrel; Pilot Projects; Protein C; Protein S; Prothrombin Time; Risk; Sensitivity and Specificity; Venous Thrombosis | 2005 |
An open label, randomized study to evaluate the effects of seven monophasic oral contraceptive regimens on hemostatic variables. Outline of the protocol. Oral Contraceptive and Hemostasis Study Group.
Topics: Blood Coagulation; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Female; Fibrin Fibrinogen Degradation Products; Fibrinolysis; Hemostasis; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Peptide Fragments; Prothrombin; Thrombin; Venous Thrombosis | 1999 |
Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study.
Topics: Adolescent; Adult; Antithrombin III; Biomarkers; Blood Coagulation; Blood Coagulation Factors; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cross-Over Studies; Desogestrel; Ethinyl Estradiol; Female; Fibrinogen; Humans; Levonorgestrel; Peptide Fragments; Peptide Hydrolases; Prothrombin; Risk Factors; Thrombin; Thrombophilia; Venous Thrombosis | 2000 |
23 other study(ies) available for desogestrel and Venous Thrombosis
Article | Year |
---|---|
Protein C and protein S deficiencies are associated with increased risk of deep vein thrombosis in pregnant women using oral contraceptives.
Topics: Antithrombins; Case-Control Studies; Contraceptives, Oral; Desogestrel; Female; Humans; Pregnancy; Pregnant Women; Protein C; Protein S Deficiency; Venous Thrombosis | 2023 |
Contraceptive Vaginal Rings: Do They Pose an Increased Risk of Venous Thromboembolism in Aesthetic Surgery?
Topics: Abdominoplasty; Administration, Intravaginal; Adult; Anticoagulants; Breast Implantation; Contraceptive Devices, Female; Desogestrel; Drug Combinations; Embolectomy; Ethinyl Estradiol; Female; Humans; Pulmonary Embolism; Risk Assessment; Risk Factors; Tomography, X-Ray Computed; Treatment Outcome; Venous Thromboembolism; Venous Thrombosis | 2015 |
Commentary on: Contraceptive Vaginal Rings: Do They Pose an Increased Risk of Venous Thromboembolism in Aesthetic Surgery?
Topics: Abdominoplasty; Breast Implantation; Contraceptive Devices, Female; Desogestrel; Ethinyl Estradiol; Female; Humans; Pulmonary Embolism; Venous Thromboembolism; Venous Thrombosis | 2015 |
The risk of venous thrombosis in women over 50 years old using oral contraception or postmenopausal hormone therapy.
Topics: Administration, Cutaneous; Age Factors; Aged; Case-Control Studies; Contraceptives, Oral, Hormonal; Desogestrel; Estradiol; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Levonorgestrel; Logistic Models; Medroxyprogesterone Acetate; Middle Aged; Netherlands; Norethindrone; Norethindrone Acetate; Odds Ratio; Postmenopause; Progestins; Risk Assessment; Risk Factors; Sex Factors; Transdermal Patch; Venous Thrombosis | 2013 |
Changes in prescription patterns of oral contraceptives in a northern Italian province: relation with venous thromboembolism.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Drug Prescriptions; Drug Utilization; Female; Humans; Incidence; Italy; Middle Aged; Norpregnenes; Progesterone Congeners; Risk Factors; Thromboembolism; Thrombophilia; Venous Thrombosis | 2003 |
The sexual health of adolescents with cystic fibrosis.
Topics: Adolescent; Anti-Bacterial Agents; Contraceptives, Oral, Hormonal; Contraindications; Cystic Fibrosis; Desogestrel; Drug Interactions; Female; Humans; Hypertension, Pulmonary; Infertility; Intrauterine Devices; Male; Pregnancy; Progestins; Puberty, Delayed; Sexually Transmitted Diseases; Venous Thrombosis | 2005 |
Use of the etonogestrel-releasing implant is associated with hypoactivation of the coagulation cascade.
Topics: Adult; alpha-2-Antiplasmin; Antithrombins; Blood Coagulation; Desogestrel; Drug Implants; Female; Fibrin Fibrinogen Degradation Products; Humans; Prospective Studies; Protein C; Protein S; Thromboembolism; Venous Thrombosis | 2007 |
Trends in prescribing patterns of hormonal contraceptives for adolescents.
Topics: Administration, Cutaneous; Administration, Oral; Adolescent; Adult; Androstenes; Child; Contraceptives, Oral, Combined; Desogestrel; Drug Prescriptions; Female; Humans; Practice Patterns, Physicians'; Risk Factors; United States; Venous Thrombosis | 2008 |
Epidemiology of oral contraceptives and cardiovascular disease.
Topics: Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Norpregnenes; Venous Thrombosis | 1998 |
Risk of venous thromboembolism with third-generation oral contraceptives: A review.
Topics: Clinical Trials as Topic; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Levonorgestrel; Norpregnenes; Risk Factors; Thromboembolism; Venous Thrombosis | 1999 |
Department of health changes advice on third generation pills.
Topics: Contraceptives, Oral, Combined; Desogestrel; Female; Humans; Norpregnenes; Patient Education as Topic; Risk Factors; Venous Thrombosis | 1999 |
Venous thromboembolic disease and combined oral contraceptives: A re-analysis of the MediPlus database.
Topics: Adolescent; Adult; Body Mass Index; Case-Control Studies; Cohort Studies; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Databases, Factual; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Norpregnenes; Odds Ratio; Risk Factors; Smoking; United Kingdom; Venous Thrombosis | 1999 |
The differential risk of oral contraceptives: the impact of full exposure history.
Topics: Adolescent; Adult; Age Factors; Alcohol Drinking; Bias; Body Mass Index; Case-Control Studies; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Norpregnenes; Regression Analysis; Risk Factors; Smoking; Venous Thrombosis | 1999 |
Recurrent use of newer oral contraceptives and the risk of venous thromboembolism.
Topics: Adult; Body Mass Index; Case-Control Studies; Contraceptives, Oral, Synthetic; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Logistic Models; Norgestrel; Norpregnenes; Risk Factors; Venous Thrombosis | 2000 |
[Sale of oral contraceptives, births and abortions prior to and after the "Marvelon issue"].
Topics: Abortion, Induced; Birth Rate; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Drug Utilization; Female; Humans; Norway; Pregnancy; Progesterone Congeners; Pulmonary Embolism; Risk Factors; Venous Thrombosis | 2000 |
Oral contraceptives.
Topics: Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral; Depression; Desogestrel; Drug Interactions; Estrogens; Ethinyl Estradiol; Female; Humans; Nausea; Progesterone Congeners; Progestins; Venous Thrombosis; Weight Gain | 2000 |
Renewed interest in haemostasis changes induced by oral contraceptives (OCs)
Topics: Activated Protein C Resistance; Adult; Biomarkers; Blood Coagulation Factors; Blood Proteins; Case-Control Studies; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cross-Over Studies; Desogestrel; Ethinyl Estradiol; Female; Genetic Predisposition to Disease; Hemostasis; Humans; Levonorgestrel; Partial Thromboplastin Time; Randomized Controlled Trials as Topic; Thrombophilia; Venous Thrombosis | 2000 |
What is the risk of venous thromboembolism (VTE) among women taking third-generation oral contraceptives (OCs) in comparison with those taking contraceptives containing levonorgestrel?
Topics: Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Desogestrel; Humans; Levonorgestrel; Norpregnenes; Progesterone Congeners; Risk Factors; Thromboembolism; Venous Thrombosis | 2001 |
Protein S levels are lower in women receiving desogestrel-containing combined oral contraceptives (COCs) than in women receiving levonorgestrel-containing COCs at steady state and on cross-over.
Topics: Adult; Analysis of Variance; Contraceptives, Oral, Combined; Cross-Over Studies; Desogestrel; Drug Administration Schedule; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Protein S; Risk; Venous Thrombosis | 2001 |
[Third generation oral contraceptives and risk of venous thrombosis].
Topics: Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Meta-Analysis as Topic; Odds Ratio; Progesterone Congeners; Risk Factors; Venous Thrombosis | 2002 |
[Changed routines in connection with first prescription of oral contraceptives. Lower risk of venous thromboembolism with levonorgestrel preparations].
Topics: Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Contraindications; Desogestrel; Drug Information Services; Drug Prescriptions; Female; Humans; Levonorgestrel; Practice Guidelines as Topic; Progestins; Risk Factors; Thromboembolism; Venous Thrombosis | 2002 |
Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills?
Topics: Biomarkers; Contraceptives, Oral, Combined; Cyproterone Acetate; Desogestrel; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Predictive Value of Tests; Risk Factors; Sex Hormone-Binding Globulin; Venous Thrombosis | 2002 |
Clinical risk factors for venous thromboembolus in users of the combined oral contraceptive pill.
Topics: Adolescent; Adult; Case-Control Studies; Contraceptives, Oral, Combined; Desogestrel; Female; Humans; Levonorgestrel; Norpregnenes; Odds Ratio; Risk Factors; Thromboembolism; Venous Thrombosis | 2002 |